Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours children under 6 months: Ask a doctor Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures includi...
store at controlled room temperature: 15°C–25°C (59°F–77°F) protect this product from excessive heat and direct sun
Obagi® Sun Shield Mineral Broad Spectrum SPF 50 Sunscreen
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Titanium dioxide 6.2% | Sunscreen |
| Zinc oxide 15.6% | Sunscreen |
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Water (Aqua), Caprylic/Capric Triglyceride, Dicaprylyl Carbonate, Pentylene Glycol, Steareth-2, Glycerin, Silica, Polyhydroxystearic Acid, Steareth-21, Cetearyl Alcohol, Propanediol, Alumina, Stearic Acid, Sodium Stearoyl Glutamate, Caprylyl Glycol, Triethoxycaprylylsilane, Cetearyl Glucoslde, Xanthan Gum, Dipotassium Glycyrrhizate,Trisodium Ethylenediamine Disuccinate, Caprylhydroxamic Acid, Tropaeolum Majus Flower/Leaf/Stem Extract
1.800.636.7546
Monday–Friday 9 a.m.–4 p.m. Pacific Time
Distributed by Obagi Cosmeceuticals LLC
Long Beach, CA 90806
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62032-910-10 | 2025-04-01 | C162847 | 48780-1 | f386c649-c7a4-0266-e053-dadaa90a7c1a | Obagi ® Skintrinsiq Firming Protocol Kit |
| 62032-910-10 | 2025-01-30 | C162847 | 48780-1 | f386c649-c7a4-0266-e053-dadaa90a7c1a | Obagi ® Skintrinsiq Firming Protocol Kit |
| 62032-910-10 | 2023-03-29 | C162847 | 48780-1 | f386c649-c7a4-0266-e053-dadaa90a7c1a | Obagi ® Skintrinsiq Firming Protocol Kit |
| 62032-910-10 | 2023-01-30 | C162847 | 48780-1 | f386c649-c7a4-0266-e053-dadaa90a7c1a | Obagi ® Skintrinsiq Firming Protocol Kit |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-811-09 | Obagi Skintrinsiq Firming Protocol | 1 in 1 CARTON | LOTION | 6.2 g in 100g | 3 | |
| 62032-811-09 | Obagi Skintrinsiq Firming Protocol | 85 g in 1 TUBE | LOTION | 85 g | 6.2 g in 100g | 3 |
| 62032-910-10 | Obagi Skintrinsiq Firming Protocol | 1 in 1 BOX | KIT | 1 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62032-811 | OBAGI SKINTRINSIQ FIRMING PROTOCOL (TITANIUM DIOXIDE AND ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Legacy NDC | 20250406_67ba9f32-bbf4-4c14-9e97-08f1cb7d3996.zip |
| 62032-910 | OBAGI SKINTRINSIQ FIRMING PROTOCOL (TITANIUM DIOXIDE AND ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC, 3 package rows | 20250406_67ba9f32-bbf4-4c14-9e97-08f1cb7d3996.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62032-910 | 62032-910-10 |
| 62032-811 | 62032-811-09 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.